Alprostadil (Prostaglandin E1) is a drug that has vasodilation properties and is used to treat erectile dysfunction and other medical conditions. This medication is available in injectable form and in suppository form. Since Prostaglandin E1 has low UV absorbance, the analysis of the formulations could be difficult. The addition of post-column derivatization increases the sensitivity and specificity of the analysis.
Analytical column: Reversed-phase C18 column (150 × 4.6 mm)
Temperature: 37 °C
Flow rate: 1 mL/min
Mobile phase: 30% Acetonitrile - 70% of 0.02 M Potassium Phosphate monobasic (adjusted to pH 3)
Mobile phase: 25% Acetonitrile – 75% of 0.0067 M Potassium Phosphate buffer pH 6.3
Injection volume: 20 µL
Post-column system: Pinnacle PCX
Reactor volume: 2 mL
Reactor temperature: 60 °C
Reagent: 1 mol/L Potassium Hydroxide
Reagent flow rate: 1 mL/min
Detection: UV 278 nm
Alprostadil: 0.1–10 µg/mL
β-Naphthol (internal standard) 0.25–10 µg/mL
Make stock solutions of Alprostadil and β-Naphthol in anhydrous Ethanol. Prepare working standards by appropriate dilution of stock solution with mobile phase.
Pickering Laboratories, Inc.
1280 Space Park Way, Mountain View, CA 94043
tel. (800) 654-3330, (650) 694-6700
Website: www.pickeringlabs.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.